Global Clinical Trial Imaging Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Clinical Trial Imaging Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Clinical Trial Imaging market size was valued at US$ 1520 million in 2024 and is forecast to a readjusted size of USD 2392 million by 2031 with a CAGR of 6.8% during review period.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of the subjects are fully protected and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of the trial results.

Clinical trial imaging plays an important role at different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and treatment effect evaluation. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

This report is a detailed and comprehensive analysis for global Clinical Trial Imaging market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Clinical Trial Imaging market size and forecasts, in consumption value ($ Million), 2020-2031

Global Clinical Trial Imaging market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Clinical Trial Imaging market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Clinical Trial Imaging market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Clinical Trial Imaging

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Clinical Trial Imaging market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Clinical Trial Imaging market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
In-house Imaging Service
Central Imaging Service

Market segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others

Market segment by players, this report covers
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Clinical Trial Imaging product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Clinical Trial Imaging, with revenue, gross margin, and global market share of Clinical Trial Imaging from 2020 to 2025.

Chapter 3, the Clinical Trial Imaging competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Clinical Trial Imaging market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Trial Imaging.

Chapter 13, to describe Clinical Trial Imaging research findings and conclusion.